by jlohrconsulting | Sep 3, 2025 | Uncategorized
Saudi Med J. 2025 Sep;46(9):1024-1032. doi: 10.15537/smj.2025.46.9.20240892. ABSTRACT OBJECTIVES: To estimate the prevalence of anxiety and depression symptoms in females awaiting preimplantation genetic diagnosis (PGD) as well as investigate their associated factors....
by jlohrconsulting | Sep 3, 2025 | Uncategorized
Environ Res. 2025 Aug 31:122733. doi: 10.1016/j.envres.2025.122733. Online ahead of print. ABSTRACT Chronic psychosocial stress is a major risk factor for major depressive disorder (MDD). The impact of 17β-trenbolone (17-TB), an anabolic steroid and potential...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
J Affect Disord. 2025 Aug 31:120184. doi: 10.1016/j.jad.2025.120184. Online ahead of print. ABSTRACT BACKGROUND: Metabolically healthy obesity (MHO) has been linked to an increased risk of cardiovascular disease, but its link to neurological and mental health remains...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
Brain Res Bull. 2025 Aug 31:111534. doi: 10.1016/j.brainresbull.2025.111534. Online ahead of print. ABSTRACT Emotion regulation is crucial for maintaining normal social interactions and individual psychological health. Using transcranial magnetic stimulation (TMS) to...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
Psych J. 2025 Sep 2. doi: 10.1002/pchj.70050. Online ahead of print. ABSTRACT Developmental researchers generally use a multi-informant approach to assess youth depressive symptoms to increase diagnostic accuracy and reliability, but informant discrepancies between...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
Gesundheitswesen. 2025 Sep 2. doi: 10.1055/a-2652-0694. Online ahead of print. ABSTRACT In 2019, the Digital Care Act introduced digital health applications as “apps on prescription” in the statutory health insurance. However, little is known about the...
Recent Comments